26th week of 2011 patent applcation highlights part 46 |
Patent application number | Title | Published |
20110159053 | PREPARATION OF A CELL CONCENTRATE FROM A PHYSIOLOGICAL SOLUTION - The present invention is directed to methods and compositions regarding the preparation of an cell concentrate, such as, for example, an osteogenic cell concentrate, from a physiological solution, such as bone marrow aspirate, blood, or a mixture thereof. In specific embodiments, the invention provides methods and compositions utilizing two physiological solution-processing techniques, particularly in a point of care environment, wherein centrifugation is not employed. | 2011-06-30 |
20110159054 | NANOPARTICULATE BICALUTAMIDE FORMULATIONS - The present invention is directed to compositions comprising an acylanilide, such as bicalutamide, having improved solubility in water. The bicalutamide particles of the composition have an effective average particle size of less than about 2000 nm, and are useful in the treatment of prostate cancer. | 2011-06-30 |
20110159055 | NUTRITIONAL SUPPLEMENT FOR USE UNDER PHYSIOLOGICALLY STRESSFUL CONDITIONS - A nutritional supplement for use in physiologically stressful conditions is disclosed. The nutritional supplement may include one or more of vitamin A, vitamin E, vitamin D3, vitamin C, vitamin B1, riboflavin, niacin, folic acid, vitamin B | 2011-06-30 |
20110159056 | METHODS AND MATERIALS FOR STIMULATING PROLIFERATION OF STEM CELLS - Disclosed herein are methods and materials for influencing proliferation of stem cells. Specifically exemplified herein are compositions comprising cerium oxide nanoparticles which can be used to stimulate proliferation of stem cells under common culture conditions, or which can be utilized to improve therapeutic outcomes. | 2011-06-30 |
20110159057 | HYDROXYAPATITE AND BIOGLASS-BASED PELLETS, PRODUCTION PROCESS AND APPLICATIONS OF THEREOF - The disclosed subject matter refers to hydroxyapatite and bioglass-based pellets of homogeneous size and spherical shape, whose interconnective porous structure, in the micrometer range, allows for an enhanced osteoconductivity and osteointegration, with specific application as a synthetic bone graft and to the respective production process. The production process is based on the pharmaceutical technology of extrusion and spheronization employing a porogenic agent and applying a sinterization stage in the presence of a vitreous liquid phase, which reverts on behalf of a higher reproducibility, superior yield and greater production capacity. Therefore, the disclosed subject matter is directed to the production of hydroxyapatite and bioglass-based pellets with applications in osteoregenerative medicine, particularly in the fields of orthopaedic surgery, maxillofacial surgery, dental surgery, implantology and as tissue engineering scaffolds | 2011-06-30 |
20110159058 | FILM PREPARATION CONTAINING LOPERAMIDE HYDROCHLORIDE - The film preparation of the present invention includes: a drug-containing intermediate layer containing loperamide hydrochloride, a terpene and a film-forming agent; and coating layers containing a film-forming agent and a plasticizer (but not a terpene) and laminated on both sides of the drug-containing intermediate layer. As a bitter taste derived from loperamide hydrochloride is thereby masked, uncomfortable sensation when taking the film preparation can be reduced. Furthermore, as this film preparation is rapidly dissolved (i.e., has a rapidly dissolving property) only with moisture in the oral cavity, it begins to work quickly and is very convenient when it is carried and taken. | 2011-06-30 |
20110159059 | Oral Care Beadlets - A single unit oral care product comprises an oral care composition comprising a polysaccharide, a secondary polymer, and a sequestrant where an outer surface of the oral care composition is encapsulated by an outer coating comprising the polysaccharide in cross-linked form. The single unit oral care product may be made by combining the gellable polysaccharide, the secondary polymer, and the sequestrant to form an oral care composition and forming at least a portion of the oral care composition into a shaped unit. The shaped unit is then immersed in an aqueous solution of a divalent salt to form a gelled oral care composition. Optionally, the gelled oral care composition may be washed with a second sequestrant. | 2011-06-30 |
20110159060 | Cosmetic Powder Bead Compositions - The present disclosure relates to beads comprising at least one structuring agent and least one powder, a novel process that forms beads of a desired size having the versatility of a loose powder but the convenience of a compact form, and compositions comprising the beads. | 2011-06-30 |
20110159061 | WIPE ARTICLE COMPRISING LOTION COMPOSITION COMPRISING OMEGA-6 FATTY ACID AND METHOD OF IMPROVING SKIN BARRIER FUNCTION - A wipe article comprising a lotion composition comprising omega-6 fatty acid. A method of improving skin barrier function of vulvar skin comprising the step of contacting the vulvar skin with a wipe article, wherein omega-6 fatty acid is disposed on the surface of the wipe article. | 2011-06-30 |
20110159062 | ANTISEPTIC COMPOSITIONS AND USES THEREOF - Antiseptic compositions and kits containing a source of silver ions and menthol, which act in synergy such that a concentration of silver ions in the composition is substantially reduced, are disclosed. Further disclosed are uses of the antiseptic compositions as disinfectants and in the treatment of wounds. | 2011-06-30 |
20110159063 | Method of Cleaning Using An Anti-Microbial Nonwoven Wipe - The present invention is directed to a method of cleaning a hard surface with a nonwoven anti-microbial hard surface wipe, and more specifically to an anti-microbial hard surface wipe that more readily releases a disinfectant or anti-microbial agent, that includes coating a nonwoven wipe having a fibrous nonwoven substrate with a non-ionic and cationic binder mixture to provide a first coated nonwoven wipe, coating the first coated nonwoven wipe with a cationic dual quaternary ammonia anti-microbial agent to provide a second coated nonwoven wipe, providing a water source, and introducing the second coated nonwoven wipe to the water source wherein the cationic dual quaternary ammonia anti-microbial agent is readily released upon the second coated nonwoven wipe being introduced to the water source. | 2011-06-30 |
20110159064 | INSECT-REPELLING RESIN COMPOSITION AND EXTENDED-RELEASE INSECT-REPELLING RESIN MOLDED PRODUCT OBTAINED THEREFROM - In order to provide a controlled-release insect-controlling resin molded product and a insect-controlling resin composition for making such a controlled-release insect-controlling resin molded product that have immediate effectiveness, residual effectiveness, and preservation stability and that are excellent in merchantability and manufacturing control, the present invention uses an insect-controlling resin composition including a polyvinyl chloride resin containing a non-vaporizable insect-controlling component and erucic acid. | 2011-06-30 |
20110159065 | AGRICULTURAL CHEMICAL COMPOSITION AND FRUIT BAG - The present invention provides an agricultural chemical composition containing an agricultural chemical active ingredient A, a sorbitan fatty acid ester and a wax, and a production process thereof. In addition, the present invention provides an agricultural chemical sheet or a fruit bag in which the agricultural chemical composition is retained, and a production process thereof. | 2011-06-30 |
20110159066 | Methods For Treating Parkinson's Disease - Methods for restoring normal patterns of activity in a subject suffering from Parkinson's Disease are disclosed that include administering an effective steady state concentration of a dopamine modulating compound continuously for a prolonged period of time such that normal patterns of activity are substantially restored in the subject. | 2011-06-30 |
20110159067 | HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF - Hydrophobic α(1→4)glucopyranose polymers useful for the preparation of implantable or injectable medical articles are described. The hydrophobic α(1→4)glucopyranose polymer includes pendent groups having hydrocarbon groups and terminal amine or hydroxyl groups. Biodegradable matrices can be formed from these polymers, and the matrices can be used for the preparation of implantable and injectable medical devices wherein the matrix is capable of degrading in vivo. Matrices including and capable of releasing a bioactive agent in vivo are also described. | 2011-06-30 |
20110159068 | Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support - An open implant constituted of an osteogenic composition comprising at least one osteogenic growth factor/amphiphilic anionic polysaccharide complex, one soluble salt of a cation at least divalent, and one organic support, said organic support comprising no demineralized bone matrix. In one embodiment, said implant is in the form of a lyophilizate. It also relates to the method for the preparation thereof. | 2011-06-30 |
20110159069 | Medical Implants and Methods of Making Medical Implants - A medical implant device having a substrate with an oxidized surface and a silane derivative coating covalently bonded to the oxidized surface. A bioactive agent is covalently bonded to the silane derivative coating. An implantable stent device including a stent core having an oxidized surface with a layer of silane derivative covalently bonded thereto. A spacer layer comprising polyethylene glycol (PEG) is covalently bonded to the layer of silane derivative and a protein is covalently bonded to the PEG. A method of making a medical implant device including providing a substrate having a surface, oxidizing the surface and reacting with derivitized silane to form a silane coating covalently bonded to the surface. A bioactive agent is then covalently bonded to the silane coating. In particular instances, an additional coating of bio-absorbable polymer and/or pharmaceutical agent is deposited over the bioactive agent. | 2011-06-30 |
20110159070 | BIOMATERIALS AND IMPLANTS FOR ENHANCED CARTILAGE FORMATION, AND METHODS FOR MAKING AND USING THEM - The invention provides products of manufacture, e.g., biomaterials and implants, for cartilage maintenance and/or formation in-vivo, in-vitro, and ex-vivo, using nanotechnology, e.g., using nanotube, nanowire, nanopillar and/or nanodepots configured on surface structures of the products of manufacture. | 2011-06-30 |
20110159071 | Isolation and Identification of Glycosaminoglycans - The isolation and identification of glycosaminoglycans capable of binding to proteins having a heparin-binding domain is disclosed, as well as the use of the glycosaminoglycans isolated in the growth and/or development of tissue. | 2011-06-30 |
20110159072 | CONTROLLED RELEASE MATRIX - A biocompatible polymeric controlled release matrix for delivery of one or more bioactive agents from an implantable medical device is described. In one embodiment, the polymeric controlled release matrix is a complaint film that includes one or more compliant biocompatible polymers and one or more bioactive agents. In another embodiment, the polymeric controlled release matrix is an elastomeric collar that includes one or more elastomeric biocompatible polymers and one or more bioactive agents. | 2011-06-30 |
20110159073 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS - Featured is a method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at least two of the following bioactive agent delivery methods (A)-(C): (A) implanting a sustained release delivery device comprising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more bioactive agents subretinally; and (C) instilling (e.g., injecting or delivering by ocular iontophoresis) one or more bioactive agents into the vitreous humor of the eye. | 2011-06-30 |
20110159074 | Wipe Article Comprising Lotion Composition Comprising Omega-6 Fatty Acid And Method Of Improving Skin Barrier Function - A wipe article comprising a composition comprising omega-6 fatty acid. A method of improving skin barrier function of semi-occluded skin comprising the step of contacting the semi-occluded skin with a wipe comprising an omega-6 fatty acid. | 2011-06-30 |
20110159075 | COMPOSITIONS AND SYSTEMS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE - Crosslinkable compositions are provided that readily crosslink in situ to provide biocompatible, nonimmunogenic crosslinked materials that may be used as adhesive compositions. The compositions comprise collagen and a plurality of crosslinkable components having reactive functional groups thereon, with the functional groups selected so as to enable inter-reaction between the components, i.e., crosslinking. Methods for preparing and using the compositions are also provided. Exemplary uses include tissue augmentation, biologically active agent delivery, bioadhesion, prevention of adhesions following surgery or injury, and coating of surgically acceptable patches and solid implants, the latter including sutures. | 2011-06-30 |
20110159076 | Autodestructive Transdermal Therapeutic System - The invention relates to a transdermal therapeutic system (TTS), preferably in the form of a transdermal plaster, that contains an active substance and an agent which can destroy the active substance. The TTS further includes a means of bringing the active substance, e.g. buprenorphine, and the agent, e.g. potassium permanganate, into contact when the TTS is removed from the skin of the patient, thereby causing the active substance to be destroyed. | 2011-06-30 |
20110159077 | PENTOXIFILIN-BASED DERMATOLOGICAL PHARMACEUTICAL COMPOSITION, FOR TOPICAL APPLICATION, IN CREAM, GEL, SOLUTION, EMULSION, LIPOSOME AND MICROCAPSULE FORM - A pharmaceutical dermatological composition based on Pentoxifylline, to be applied on the skin in the form of a cream, gel, unguent, solution, in an emulsion, in liposomes and in microcapsules, being selective for the vascular disorders of rosacea and disorders with photosensitivity, reducing the blood vessels and the reactions of reddening of the skin, CHARACTERIZED in that said composition consists of: from 1% to 99% of Pentoxifylline, from 0.1% to 80% of base cream and from 0.1% to 75% of liposomes. | 2011-06-30 |
20110159078 | Volatile Anesthetic Compositions and Methods of Use - The present invention provides methods for reducing pain in a subject in need thereof by delivering a volatile anesthetic in a solution or an emulsion that can additionally include an extractive solvent in an amount effective to reduce pain without substantially interfering with motor function. Chronic or acute pain may be treated, or the volatile anesthetic may be delivered as a regional anesthetic to a subject to anesthetize a portion of the subject prior to surgery. Dosing regimes including a one-time administration, continuous and/or periodic administration are contemplated. | 2011-06-30 |
20110159079 | High Delivery Rates for Lipid Based Drug Formulations, and Methods of Treatment Thereof - Provided is a method of preparing lipid based drug formulations with low lipid/drug ratios using coacervation techniques. Also provided are methods of delivering such lipid based drug formulations at high delivery rates, and methods of treating patients with pulmonary diseases comprising administering such lipid based drug formulations. | 2011-06-30 |
20110159080 | COMPOSITION COMPRISING LIPOSOME-ENTRAPPED DOXORUBICIN AND METHODS OF ADMINISTRATION - Patients suffering from cancer, such as ovarian cancer, may be treated by administering an effective combined amount of a liposomal-entrappeddoxorubicin, an alkylating antineoplastic agent, and a vascular endothelial growth factor inhibitor. In one embodiment, patients suffering from ovarian cancer are treated by administering an effective combined amount of the liposome-entrapped doxorubicin product DOXIL, carboplatin and bevacizumab. | 2011-06-30 |
20110159081 | VACCINE - The present invention provides an immunogenic composition comprising at least one antigen delivery particle and at least one antigen, wherein the antigen and antigen delivery particle are linked using an intermediate linker. | 2011-06-30 |
20110159082 | PHARMACEUTICAL COMPOSITION CONTAINING FENOFIBRATE AND METHOD FOR THE PREPARATION THEREOF - The invention concerns a pharmaceutical composition containing micronized fenofibrate, a surfactant and a binding cellulose derivative, as solubilizing adjuvant, preferably hydroxypropylmethylcellulose. The cellulose derivative represents less than 20 wt. % of the composition. The association of micronized fenofibrate with a binding cellulose derivative, as solubilizing adjuvant and a surfactant enables enhanced bioavailability of the active principle. The invention also concerns a method for preparing said composition without using any organic solvent. | 2011-06-30 |
20110159083 | Nanoparticles for protein drug delivery - The invention discloses nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent characterized with a positive surface charge. The bioactive agent is hydrophobic or lipophilic in nature and is associated with micelles before being encapsulated in nanoparticles. | 2011-06-30 |
20110159084 | RALOXIFENE PHARMACEUTICAL FORMULATIONS - Pharmaceutical formulations comprising raloxifene or its salts, esters, polymorphs, isomers, hydrates, solvates, or derivatives thereof having defined particle sizes. Also described are processes for preparing formulations and methods of using such formulations. | 2011-06-30 |
20110159085 | ABT-263 CAPSULE - A pharmaceutical capsule comprises a shell having encapsulated therewithin a liquid solution of ABT-263 or a pharmaceutically acceptable salt thereof in a substantially non-ethanolic carrier that comprises as pharmaceutically acceptable excipients (a) at least one phospholipid, (b) at least one solubilizing agent for the at least one phospholipid, selected from the group consisting of glycols, glycerides and mixtures thereof, (c) at least one non-phospholipid surfactant and (d) at least one sulfur-containing antioxidant. The capsule is useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer. | 2011-06-30 |
20110159086 | PHARMACEUTICAL FORMULATION COMPRISING A CB1-RECEPTOR COMPOUND IN A SOLID SOLUTION AND/OR SOLID DISPERSION - The present invention relates to a pharmaceutical formulation comprising 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-(cis-2,6-dimethylpiperidin-1-yl)-4-methyl-4,5-dihydro-1H-pyrazole-3-carboxamide as racemate or (S)-enantiomer or mixtures thereof in a solid solution and/or solid dispersion. | 2011-06-30 |
20110159087 | Crosslinked Polymers - Disclosed herein are pharmaceutical compositions comprising wet granulated bile acid sequestrants having the general Formula I shown, and their process of preparation. The present invention also discloses process for preparation of Colesevelam hydrochloride, an antilipemic agent. | 2011-06-30 |
20110159088 | ORAL PHARMACEUTICAL FOR BASED ON AT LEAST ONE ACTIVE PRINCIPLE WHOSE SOLUBILITY VARIES AS A FUNCTION OF THE GASTRIC pH CONDITIONS - The field of the present invention is that of oral pharmaceutical forms of at least one active principle AP whose solubility varies greatly as a function of the gastric pH, and also treatments and administration methods relating thereto. | 2011-06-30 |
20110159091 | RAPIDLY DISPERSIBLE VAGINAL TABLET THAT PROVIDES A BIOADHESIVE GEL - A tablet for insertion into a vagina including 0.01 to 500 mg of a vaginal medication, such as a microbicide, such as cellulose acetate 1,2-benzenedicarboxylate (CAP); 100 to 500 mg of mannitol powder; 50 to 300 mg of inert microcrystalline cellulose; 10 to 80 mg of hydroxypropyl methylcellulose; 50 to 250 mg of glycerol and optionally 2 to 4 mg of at least one preservative which protects against microbicidal contamination and discourages the growth of yeast in the vagina. The tablet which includes CAP as the vaginal medication is vaginally administered before coitus in methods for preventing the sexual transmission of HIV-1, HIV-2, herpesvirus, or an infection caused by | 2011-06-30 |
20110159092 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING LINEZOLID AND PROCESS FOR PREPARING THE SAME - The present invention provides an extended release pharmaceutical composition suitable for once daily dosing comprising Linezolid or pharmaceutically acceptable salt, derivative, prodrug, metabolite and polymorph thereof and one or more pharmaceutically acceptable excipients and a process of preparing the same. The present invention further provides a method of treating bacterial infections in a mammal comprising administering an extended release, pharmaceutical composition suitable for once daily dosing comprising Linezolid capable of maintaining T>MIC for at least 24 hours. The present invention further provides an extended release pharmaceutical composition suitable for once daily dosing comprising Linezolid so that upon oral administration the maximum concentrations (C | 2011-06-30 |
20110159093 | MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS - Disclosed herein are multiparticulate modified release pharmaceutical compositions comprising: (a) a first portion comprising an active ingredient, at least one surfactant and at least one release modifying agent and (b) a second portion comprising an active ingredient and optionally a release modifying agent. Particularly, the active ingredient in the first portion is a calcium channel blocker and the modified release composition is in the form of a multiparticulate tablet. | 2011-06-30 |
20110159094 | EXTENDED RELEASE COMPOSITIONS FOR HIGH SOLUBILITY, HIGH PERMEABILITY ACTIVE PHARMACEUTICAL INGREDIENTS - A novel composition comprising a tablet, comprising a highly soluble active pharmaceutical ingredient, which is then coated with a coating. The core is preferably a tablet. The coating preferably comprises any type of suitable extended release polymer, with the proviso that the polymer does not comprise an enteric polymer. | 2011-06-30 |
20110159095 | TREATMENT OF ADRENAL INSUFFICIENCY - The disclosure relates to a pharmaceutical formulation, for example a tablet, adapted for delayed and sustained release of hydrocortisone and a treatment regime that uses said tablet in the treatment of adrenal insufficiency. | 2011-06-30 |
20110159096 | 1-(1H-1,2,4-Triazol-1-YL)Butan-2-OL Derivative For Pharmaceutical Use, and The Use Of a 1-(1H-1,2,4-Triazol-1-YL)Butan-2-OL Derivative With Substantially Undefined Crystal Shape For Preparing Said 1-(1H-1,2,4-Triazol-1-YL)Butan-2-OL Derivative - The present invention relates to voriconazole, processes of preparing voriconazole, and pharmaceutical compositions and therapeutic uses thereof. In particular, the present invention also relates to voriconazole prepared from voriconazole having a substantially undefined shape and/or crystal habit. The invention further relates to voriconazole having a modified sphericity factor and/or specific surface area and/or Sauter diameter compared to voriconazole known from the prior art. | 2011-06-30 |
20110159097 | EXTRACT OF THE PLANT RAVENALA MADAGASCARIENSIS AND USE AS COSMETIC HYDRATING AGENT - An extract is from the plant | 2011-06-30 |
20110159098 | STABILIZATION AND DELIVERY OF NUCLEIC ACID COMPLEXES - Compositions and methods for delivering nucleic acid, including siRNA, to a target cell are provided. In one embodiment, the composition includes the nucleic acid and a stabilizing protein. In another embodiment, the nucleic acid is complexed with a carrier, for example, a peptide carrier. In yet another embodiment, the nucleic acid combined with a protein which is cross-linked to form a proteinaceous controlled release matrix. Methods for making the compositions are also described. | 2011-06-30 |
20110159099 | BONE-FILLING TYPE AGENT FOR INDUCING CARTILAGE REGENERATION - Provided is a medical material which enables a novel treatment method for cartilage regeneration being different from a treatment method through transplantation of autologous cartilage, a cartilage alternative or undifferentiated cells. Provided is a bone-filling type agent for inducing cartilage regeneration comprising a hydrogel which contains, as a monomer unit, an acid having an acidic group and/or a salt obtained by adding a metal to an acidic group and does not contain an interpenetrating network structure or a semi-interpenetrating network structure composed of two or more polymers. The bone-filling type agent for inducing cartilage regeneration can induce natural cartilage regeneration in the body by filling it in a hole or a groove provided in subchondral bone beneath cartilage defect. | 2011-06-30 |
20110159100 | FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES - Controlled release formulations and methods for preparing controlled release formulations for delivery of active drug substances are described herein. The formulations described herein may be employed to produce pharmaceutical compositions, such as controlled release dosage forms, adjusted to a specific administration scheme. | 2011-06-30 |
20110159101 | SILYL ETHER-MODIFIED HYDROPHILIC POLYMERS AND USES FOR MEDICAL ARTICLES - Silane-functionalized hydrophilic polymers and polymeric matrices are described. Hydrophilic matrices can be formed from the polymers, and can be used in association with the preparation of implantable and injectable medical devices. Exemplary devices include those having a durable lubricious coating formed from the hydrophilic polymers. | 2011-06-30 |
20110159102 | Apparatus and Method for Continuous Production of Spherical Powder Agglomerates - The disclosure relates to a process for continuously producing spherical powder agglomerates, in which morphologically irregular starting agglomerates of micronized pulverulent particles are rounded off continuously by application to a surface induced to vibrate. | 2011-06-30 |
20110159103 | Novel Preparation of an Enteric Release System - Hydrophobic liquids are microencapsulated by an enteric matrix in an environment substantially free of organic solvents. The process includes forming an emulsion of the enteric material and hydrophobic liquid in water, titrating the emulsion with an acid to form a particulate precipitate and optionally coating the particulate with a combination of enteric material and plasticizer. | 2011-06-30 |
20110159104 | MICROEMULSION - The present invention relates to biocompatible microemulsions based on honey which can additionally comprise both water-soluble and also fat-soluble active ingredients in stable form. Via the microemulsion bioavailable nutrients bonded in the honey, preferably together with further active substances, are introduced by topical application into the skin or orally, nasally or percutaneously into the body where they develop their positive effects. These emulsions can be prepared easily and are used both in medicine/veterinary medicine, dermatology and also in cosmetics. Moreover, the honey microemulsions can be used on their own or with nutritionally relevant substances in the fields of foodstuff, functional foods, food supplements or dietetic products. | 2011-06-30 |
20110159105 | PERSONAL CARE PRODUCTS CONTAINING RAINWATER - This invention relates generally to formulations and methods for improving level of moisture absorption and retention by the skin and for improving the appearance, feel, or comfort of the skin, wherein the formulations comprise pure rainwater. In another embodiment of the invention, the formulations comprise a combination of natural extracts. The present invention is a formulation made substantially without the use of synthetic chemicals and petroleum by-products, wherein the formulation is used for personal care. More specifically, the present invention is a skin care product formulation wherein 90% or more of the ingredients are natural products. | 2011-06-30 |
20110159106 | DERMATOLOGICAL COMPOSITIONS CONTAINING AN ASSOCIATION OF PEROXIDIZED LIPIDS AND ZINC, AND USES THEREOF IN PARTICULAR IN THE TREATMENT OF HERPES - A dermatological composition containing an association of peroxidized lipids; and zinc in mineral form or zinc compound compatible with dermatological use, formulated for topical application on the skin or the mucous membranes, is disclosed compatible with dermatological use. The composition may be used as a medical device to assist in healing and/or reconstitution of a damaged epidermis and/or to act as an analgesic agent on the skin or the mucous membranes, in particular in the treatment of the symptoms of herpes, pruritus, itching, irritations, eczema, burns, and most particularly in the treatment of labial or genital herpes. | 2011-06-30 |
20110159107 | Pesticidal Mixtures Comprising Isoxazoline Compounds II - The present invention relates to pesticidal mixtures comprising as active components
| 2011-06-30 |
20110159108 | GERM GUARD LID AND METHODS FOR USING GERM GUARD LID - Described herein is a beverage lid that is itself treated with and/or impregnated with antimicrobial material to prevent the spread of contaminants and methods of making and using the same. The beverage lid can prevent spread of contaminants, including communicable diseases like influenza, the common cold, streptococcus or staphylococcus. For example, when a person carrying germs, like influenza, touches a beverage lid, the antimicrobial properties of the beverage lid can combat any contamination of the beverage lid by the germs. Another person can drink from the beverage lid that is substantially germ free. | 2011-06-30 |
20110159109 | TITANIA DISPERSION AND METHOD FOR MAKING - A novel method for preparing a titania dispersion by blending two different titania dispersions synthesized by a solvothermal process and a hydrolysis process. The titania dispersion has a plurality of titania particles substantially uniformly dispersed therein and can be blended to provide a high concentration of titania with an anatase crystalline structure to provide the desired level of photocatalytic activity. The present invention also permits the preparation of transparent titania dispersions. The solution may be used for various decontamination and clean energy generation applications. | 2011-06-30 |
20110159110 | PLANT DISEASE CONTROL AGENT - The present invention provides a plant disease control agent containing at least one of tetrazoyloxime derivatives and salts thereof, and at least one selected from the group consisting of fosetyl, propamocarb, basic copper chloride, chlorothalonil, manzeb, cymoxanil, folpet, iminoctadine, cyazofamid, metalaxyl, fludioxonil, tebuconazole, prothioconazole, thiamethoxam, azoxystrobin and salts thereof. | 2011-06-30 |
20110159111 | PHARMACEUTICAL COMBINATIONS - The invention provides combinations of an ancillary compound of the formula (0): and a compound of the formula (I′): Also provided are crystalline forms of the constituent compounds, methods for making them and their uses in treating cancers. | 2011-06-30 |
20110159112 | Recombinant alpha-fetoprotein and compositions thereof - Disclosed are pharmaceutical and synergistic compositions comprising human recombinant alpha-fetoprotein expressed in eucaryotic cells for preparation of therapeutic agents for use in oncology, immunotherapy, stem cell therapy and cosmetology and also for the diagnosis of cancer and embryonic pathologies. | 2011-06-30 |
20110159113 | HYPERBRANCHED POLYESTER AND A METHOD OF SYNTHESIZING A HYPERBRANCHED POLYESTER - The various embodiments herein provide a hyper branched polyester and a method of synthesizing the same. The embodiments herein also provide a method of encapsulating a drug into the void spaces of the polymer to act as a drug delivery system. The hyper branched polyester mer comprises an acidic moiety and an alcoholic moiety. The acidic moiety is citric acid monohydrate. The alcoholic moiety is glycerol. The acidic moiety and the alcoholic moiety are randomly arranged in the hyperbranched polymer. The method comprises of heating the mixture of citric acid and glycerol at temperatures of 90 to 150° C. by constant stirring for different time periods. In the method of encapsulation, the drug solution is drop-wise added to polymer solution at 37° C. by constant stirring for 24 h. | 2011-06-30 |
20110159114 | COMBINATION COMPRISING AN IRON CHELATOR AND AN ANTI-NEOPLASTIC AGENT AND USE THEREOF - The present invention relates to a combination comprising a a substituted 3,5-diphenyl-1,2,4-triazole, e.g. 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid and at least one anti-neoplastic agent and to the use of said combination for the preparation of a medicament for the treatment of proliferative diseases. | 2011-06-30 |
20110159115 | Massive Bodies Containing Free Halogen Source For Producing Highly Converted Solutions of Chlorine Dioxide - A massive body, e.g., a tablet, for producing a thickened solution of chlorine dioxide when the massive body is added to liquid water is disclosed. The massive body comprises a metal chlorite, an acid source and a thickener (incorporated directly into the massive body or added as a component separate from the massive body) and optionally a source of free halogen. The concentration of free chlorine in the solution will be: (a) less than the concentration of chlorine dioxide in said solution on a weight basis and the ratio of the concentration of chlorine dioxide to the sum of the concentrations of chlorine dioxide and chlorite anion in said solution is at least 0.25:1 by weight; or (b) equal to or greater than the concentration of chlorine dioxide in said solution on a weight basis and the ratio of the concentration of chlorine dioxide to the sum of the concentrations of chlorine dioxide and chlorite anion in said solution is at least 0.50:1 by weight. | 2011-06-30 |
20110159116 | BIOCOMPATIBLE MATERIALS FOR MEDICAL DEVICES - The present disclosure is directed to a method of producing nitric oxide comprising (i) providing a composition comprising a metal-organic framework, and (ii) exposing the composition to a nitric oxide-releasing compound. The disclosure also is directed to compositions, coatings, and medical devices comprising a metal-organic framework. | 2011-06-30 |
20110159117 | Synergistic Biocide and Process for Controlling Growth of Microoganisms - Synergistic mixtures of haloamines and their use to control the growth of microorganisms in aqueous systems are disclosed. The method of using the synergistic mixtures entails adding an effective amount of a monohaloamine and an effective amount of a dihaloamine to an aqueous system. The ratio of monohaloamine to dihaloamine is selected to result in a synergistic biocidal effect. | 2011-06-30 |
20110159118 | Screening Method (Metabolite Grid) for Therapeutic Extracts and Molecules for Diabetes - The present invention provides therapeutic compositions derived from plants useful for treating diabetes. The present invention also provides methods for screening plant metabolites and constituents to identify therapeutic agents and/or dietary supplements for treating diabetes. The therapeutic compositions can be derived from plants such as | 2011-06-30 |
20110159119 | COMPOSITIONS AND METHODS FOR ARACHNID CONTROL - The invention provides compositions and methods for treating or preventing infestation of a site with a spider. | 2011-06-30 |
20110159120 | SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACTS - The present invention discloses synergistic nutraceutical or pharmaceutical or dietary supplement anti-inflammatory compositions comprising therapeutically effective combination of an extract selectively enriched in 3-O-acetyl-11-keto-β-boswellic acid (AKBA) derived from | 2011-06-30 |
20110159121 | METHODS AND COMPOSITIONS FOR IDENTIFYING, PRODUCING AND USING PLANT-DERIVED PRODUCTS FOR MODULATING CELL FUNCTION AND AGING - Provided herein are methods of culturing cells in vitro in order to exploit the biochemical production ability of the cells to make metabolites that are evaluated and harvested for their biological effects. Also provided are systems for evaluating extracts from such cultured cells to characterize their biological activity(s), particularly with regard to impact on health, wellbeing, longevity, DNA maintenance, mitochondrial health and/or biogenesis, and so forth. Biologically active extracts, components thereof, and compositions (such as cosmetic or pharmaceutical preparations) made comprising such, are also provided. | 2011-06-30 |
20110159122 | COMBINATION OF EXTRACTS OF VARIOUS PLANTS FOR IMPROVING THE SYMPTOMS OF DEMENTIA DISORDERS - The present invention relates to combinations of extracts of various plants. A plant extract is obtained from unfermented rooibos by extraction with a mixture of water and alcohol. The rooibos extract contains a compound of formula I (aspacat). The compound of formula I is shown below: | 2011-06-30 |
20110159123 | Composition For Relieving Premenstrual Syndrome - A composition is provided for relieving premenstrual syndrome. The composition comprises about 5% to about 95% by weight of a tribulus terrestris extract and about 5% to about 95% by weight of one or more herbal extracts selected from organic white willow extract, Red raspberry leaf extract, Chaste tree berry extract, Cramp bark extract, and Gingko biloba extract. The composition further comprises dehydroepiandrosterone, amino acids, vitamins and derivatives thereof, minerals and derivatives thereof, carbohydrates, citric acid, natural flavors, stevia, juice powder, maltodextrin, and silicon dioxide. The vitamins and derivatives thereof comprise, for example, vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin B9, vitamin B7, vitamin C, vitamin D3, and d-calcium pantothenate. The minerals comprise, for example, calcium, magnesium, manganese, sodium, and potassium. The ingredients are mixed in a liquid carrier and administered as a hot or cold beverage. | 2011-06-30 |
20110159124 | Compositions and methods useful for treatment of respiratory illness - Disclosed herein are compositions and methods useful for the treatment of respiratory illness in a mammal, such as wherein these compositions and methods are effective in preventing the onset of one or more of the symptoms of such respiratory illness or significantly mitigating the symptom if the mammal is already afflicted with such symptom. The compositions used in the methods herein include a first component selected from the group consisting of | 2011-06-30 |
20110159125 | CGRP Compositions and Uses Thereof - Compositions comprising at least one ingredient that stimulates, enhances, or increases CGRP expression, and a physiologically- or cosmetically-acceptable vehicle. The ingredient may be a compound, natural ingredient, such as a plant or fungus, derivatives, analogs, mimetics, synthetics and the like that stimulates CGRP expression. The CGRP plant includes plants, plant materials, plant extracts, synthetics, or combinations thereof that stimulate CGRP expression. The disclosure is also directed to methods of using the CGRP compositions for decreasing, reducing, or inhibiting fine lines or wrinkled skin. | 2011-06-30 |
20110159126 | Composition and method for exfoliating skin - Disclosed is an exfoliating composition and method for removing dead skin cells from the surface of human skin. The composition is a physiologically effective amount of ground up cucumber or cucumber extract in a suitable carrier. The carrier can be water, alcohol, or mixtures thereof. The method is to administer a physiologically effective amount of the composition to an individual seeking to exfoliate skin. The composition is rubbed into the skin, and loosens dead cells, which are then physically removed from the surface of the skin. | 2011-06-30 |
20110159127 | EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASES, THE PREPARATION METHOD AND THE USE THEREOF | 2011-06-30 |
20110159128 | ALCOHOL METABOLISM ENHANCER AND ALCOHOLIC BEVERAGE - An alcohol metabolism enhancer is made from safe plant extracts and an alcoholic beverage and causes a reduced sick feeling and hangover from drinking alcohol without causing hemolysis using safe materials derived from plants. The alcohol metabolism enhancer and the alcoholic beverage include proanthocyanidins, such as pine bark extracts. | 2011-06-30 |
20110159129 | USE OF CLERODENDRUM SP. FOR TREATING TIC DISORDERS OR PSYCHIATRIC DISORDERS WITH SENSORIMOTOR GATING DEFICITS - The present invention relates to the use of a composition made from | 2011-06-30 |
20110159130 | REDUCTION OF ENDOTOXIN IN POLYSIALIC ACIDS - The present invention relates to process for reducing the endotoxin content of a sample of fermentation broth containing polysialic acid and endotoxin comprising the sequential steps: (i) adding to the sample a base having a pKa of at least 12 to form a basic solution having a pH of at least 12, incubating the solution for a pre-determined time at a pre-determined temperature; and (ii) recovery of PSA, suitably by (iii) passing the sample through an anion-exchange column whereby polysialic acid is absorbed on the ion exchange resin; (iv) washing the column with one washing buffer, whereby polysialic acid remains absorbed on the ion exchange resin; and (v) eluting the polysialic acid from the column using an elution buffer to provide a product solution of polysialic acid having reduced endotoxin content. | 2011-06-30 |
20110159131 | USE OF STRAINS OF LACTOBACILLUS AND BY-PRODUCTS THEREOF FOR INHIBITING FORMATION OF BLOOD VESSELS - A lactic composition containing at least a bacterial strain selected from the group consisting of | 2011-06-30 |
20110159132 | AUTOMATIC GREASE SUPPLY DEVICE OF INJECTION MOLDING MACHINE - A lubricant such as grease is supplied by a grease supply device to a grease supply point of an injection molding machine. A workload of a movable portion forming the injection molding machine when the movable portion operates is calculated and a grease supply command is output to the grease supply device when the calculated workload exceeds a reference value. An operating state of the injection molding machine is evaluated by using the workload reflecting a load on the movable portion and, in this way, insufficiency of lubrication of the movable portion is anticipated. | 2011-06-30 |
20110159133 | Injection Molding Machine - Provided is an injection molding machine using a built-in type motor as a measuring electric servomotor. In order to reduce the entire length of the machine (the injection molding machine), the metering electric motor is exemplified by a hollow built-in type motor, which includes a cylindrical stator, and a cylindrical rotor positioned in the stator. A sleeve is fixed in the rotor of the built-in type motor, and a member fixing the rear end portion of a screw and the sleeve are connected/fixed. Moreover, a nut member as a straight portion of a ball screw mechanism for converting the rotation of an injecting electric motor into linear motions and the sleeve are connected/fixed. | 2011-06-30 |
20110159134 | METHOD OF PRODUCING A MOLD FOR IMPRINT LITHOGRAPHY, AND MOLD - In order to prevent occurrence of a residual film distribution dependent upon a pattern density of a mold, in producing the mold to be used for imprint lithography, by etching using a mask, use is made of a first mask M | 2011-06-30 |
20110159135 | SYSTEM FOR PRODUCING HIGH INTERNAL PHASE EMULSION FOAM - A system for continuous High Internal Phase Emulsion (HIPE) foam production. A HIPE is produced then extruded onto a carrier sheet positioned on a belt surface. | 2011-06-30 |
20110159136 | MOLD ASSEMBLY - A mold assembly that forms an expansion molded body by expanding foam raw material inside a cavity, includes a first die, a second die that closes together with the first die, wherein a sealed cavity is formed between the first die and the second die when the first die and the second die are closed, and a sealing member that is provided on at least one of the first die or the second die and seals the cavity, wherein at least one of a first space that is on a side of the sealing member that faces the cavity and leads to the cavity, or a second space that is formed inside the sealing member and leads to the cavity, is formed when the first die and the second die are closed. | 2011-06-30 |
20110159137 | TABLET COMPRESSION DIE - A tablet compression die configured such that formation of edges on the surface of a tablet is suppressed when the tablet is integrally formed by compression. A tablet compression die is provided with a space (S) into which rods ( | 2011-06-30 |
20110159138 | BLOW MOLD FOR MOLDING A CONTAINER - A blow mold is disclosed. The mold includes a pair of mold halves having an operative configuration wherein the mold halves together define a cavity for a container, the container having a main body and a characteristic selected from the group of characteristics consisting of: a push-up base; an integral finish; and an embossed or a debossed feature. Each of the pair of mold halves has a first portion and a second portion formed integrally with the first portion. When the pair of mold halves is in the operative configuration, the first portions collectively define the main body and the second portions collectively define the characteristic. At least one of the pair of mold halves has a relatively soft substrate portion and a relatively hard surface layer formed integrally with the substrate portion. | 2011-06-30 |
20110159139 | HEATING APPARATUS FOR FLUID FLOW CHANNEL - Apparatus for heating a fluid being injected in an injection molding system, the apparatus comprising a mold having a cavity, a fluid flow distribution manifold, a fluid flow channel body, a coiled heater tube comprised of a thermally conductive wall, a heater device disposed within the coiled tube; the coiled tube having an upstream, downstream and intermediate coiled portions, the upstream and downstream coiled portions of the coiled tube being selectively movable away from each other along the coil axis to cause the intermediate coiled portion of the coiled tube to stretch or extend in coil axial length. | 2011-06-30 |
20110159140 | MOLD STRUCTURE FOR INJECTION MOLDING - A mold structure includes a first base which has a first indention area, a first main runner spaced from the first indention area, and a plurality of first subordinate runners communicating with the first indention area and the first main runner, and a second base which has a second indention area corresponding to the first indention area, a second main runner corresponding to the first main runner, and a plurality of second subordinate runners corresponding to the first subordinate runners and communicating with the second indention area and the second main runner. A plurality of first mold cores and corresponding second mold cores is mounted to the first indention area and the second indention area, respectively. The second mold core is engaged with the first mold core to form a mold chamber communicating with a chamber formed by the first indention area and the second indention area. | 2011-06-30 |
20110159141 | COOLING CONFECTIONERIES AND BEVERAGES - Edible compositions, including chewing gums, confectioneries, and beverages, include particular cooling agents that may be used alone, in combination with each other, or in combination with other cooling agents. The cooling agents may, optionally, be treated to modify their release profile. The edible compositions provide a pleasant cooling sensation while reducing or eliminating undesirable characteristics associated with the use of menthol alone as a cooling agent. | 2011-06-30 |
20110159142 | SUGAR FREE CONFECTIONERY; METHODS OF MAKING SAME; AND USE IN PREPARING MULTILAYERED CONFECTIONERY - Disclosed are sugar free confectionery products, methods of making, and multilayer structures prepared from the confectionery products and chewing gum. | 2011-06-30 |
20110159143 | MULTILAYERED SUGAR FREE MANNITOL CONFECTIONERY AND METHODS OF MAKING SAME - Disclosed are sugar free confectionery products, methods of making, and multilayer structures prepared from the confectionery products and chewing gum. | 2011-06-30 |
20110159144 | IMPROVED METHOD OF BREWING BEER - The invention is related to a method of brewing beer comprising the steps of fermenting wort in a batch fermenter, and centrifuging the fermented wort, wherein the centrifuging step is done by using a disc stack centrifuge. | 2011-06-30 |
20110159145 | IMPROVED EDIBLE COMPOSITIONS AND METHOD FOR PREPARING IT - The invention relates to an oat suspension, a process for preparation thereof and a powder made thereof. The suspension and the powder can be used for preparing drinks and other non-dairy products with improved sensory properties. | 2011-06-30 |
20110159146 | VITAMIN ENRICHED FOODSTUFFS - The invention relates to a method for vitamin enrichment of foodstuffs containing ascomyceta such as yeast where ergosterol in the foodstuff is transformed into vitamin D | 2011-06-30 |
20110159147 | METHOD FOR PRODUCING FROZEN VEGETABLE FOOD MATERIAL HAVING SOFT TEXTURE - Provided is a method for producing a frozen soft vegetable food material which is suitable as a food for the aged, whose original shape is not damaged even in the circulation process, which has uniform softness even in the interior thereof and which can maintain its original shape. | 2011-06-30 |
20110159148 | INCREASED FOLATE PRODUCTION LEVELS IN LACTOBACILLUS FERMENTING MELON JUICE - The invention relates to the field of food, feed and food supplements comprising high folate levels, whereby the folate is produced by fermentation of | 2011-06-30 |
20110159149 | PERFORMANCE OF COMPANION ANIMAL PALATABILITY SYSTEMS LEADING TO INCREASED PET FOOD CONSUMPTION PREFERENCES - The invention concerns a palatability enhancing composition comprising at least one palatant and/or at least one tasteant modified by glycerol and/or propylene glycol. Said palatability enhancing composition is intended to be applied onto the surface of a companion animal food. The invention also extends to companion pet foods which are prepared with such palatability enhancing composition. | 2011-06-30 |
20110159150 | METHOD AND APPARATUS FOR PRODUCING MINERAL WATER - A mineral water producing method includes the steps of inputting basic data to obtain data about human mineral intake and data about average mineral intake from food; selecting a water supply area to obtain data about mineral intake from daily water intake; selecting an eating habit and a physical/mental condition; inputting personal body weight and calculating mineral intake; setting a daily water intake and calculating a daily mineral supplement; and outputting mineral water. A mineral water producing apparatus includes a water inlet and a water outlet; a first filter being connected at a first end to the water inlet and at a second end to the water outlet; at least one mineral substance container being located between and connected to the second end of the filter and the water outlet; and a controller for controlling the mineral substance container to supply a mineral substance. | 2011-06-30 |
20110159151 | MISO - The present invention provides miso containing a flavonoid substance having a flavanone, flavone, or flavonol skeleton in an amount of 0.01 to 5% by mass (weight). | 2011-06-30 |
20110159152 | MICROCAPSULES, METHOD OF PRODUCING THE MICROCAPSULES AND FOOD AND DRINK CONTAINING THE MICROCAPSULES - A method of producing microcapsules that comprises an emulsification step in which a fat-soluble substance and a sodium alginate aqueous solution are mixed to obtain an emulsified liquid in which there are dispersed emulsified particles composed of the fat-soluble substance and having a mean particle size of not greater than 800 nm, and a spraying step in which the emulsified liquid is sprayed into a calcium ion-containing solution to obtain microcapsules in which the emulsified particles are encapsulated. | 2011-06-30 |
20110159153 | GRILLED CHEESE SANDWICH FOR THE TOASTER - A freezable, toaster reheatable grilled cheese sandwich, and a method for making this type of sandwich, are described. The grilled cheese sandwich has organoleptic properties that are identical or substantially identical to a homemade, made-from-scratch grilled cheese sandwich. | 2011-06-30 |
20110159154 | JELLY CONFECTIONERY - The invention relates to methods of producing jelly confectionery products, and to jelly confectionery products themselves. The centre-filled jelly confectionery comprises—a centre filling, —a casing, and —a backing layer, wherein the backing layer has a different visual appearance compared to the casing. According to one embodiment, the centre filling is coloured, the casing comprises a colouring agent, and the backing layer comprises said colouring agent of the casing, at a concentration that is greater than in the casing. According to another embodiment, the centre filling is coloured, the casing is uncoloured, and the backing layer is coloured. There is also provided a method for making a centre-filled jelly confectionery, the method comprising: (a) preparing a liquid jelly confectionery composition comprising bulk sweetener and a hydrocolloid gelling agent, (b) cooking the liquid jelly confectionery composition, (c) depositing the liquid jelly confectionery composition into a mould, (d) depositing the centre filling into a mould so that the liquid jelly confectionery composition deposited in (c) forms a casing around the centre filling to produce a casing containing a centre filling, and (e) applying a backing layer to the casing containing a centre filling, wherein the backing layer is provides a different visual appearance compared to the casing, to form the centre-filled jelly. Steps (c) and (d) can be preformed by co-depositing the liquid jelly confectionery composition and centre filling into the mould. | 2011-06-30 |